Bendulo, Zuriel D.

HRN: 27-84-94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
CEFUROXIME 750MG (VIAL)
02/23/2026
03/02/2026
IV
300 Mg
Q 8 Hours
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: